Drawing for HEALTHY CHOICES

USPTO serial 98503294

HEALTHY CHOICES

Reviewed by CopyMark Law Group

Status 731Notice of Allowance
Filing date
Status date
Registration date
—
Examiner
SWAIN, MICHELE LYNN
Law office
INTENT TO USE SECTION

What this means

The USPTO has issued a Notice of Allowance. To complete registration you generally need to file a Statement of Use or an extension request before the deadline.

Status 731: Status 731 means the second six-month extension to file a Statement of Use was granted. File a Statement of Use or the next extension before the deadline expires.

Need help with HEALTHY CHOICES?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Notice of Allowance, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $947*

Plus Government fees of $450

Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Benjamin W. Janke

Benjamin W. Janke Baker, Donelson, Bearman, Caldwell & Berkowitz, A Professional Corporation201 St. Charles Ave., Suite 3600New Orleans, LA 70170United States

Goods and services

ClassDescriptionStatusFirst use
035Providing online information in the field of consumer product information lists relating to pharmaceuticals, price comparisons, cost price analysis and price quotations being a guaranteed pricing program service of pharmaceuticals and retail store services featuring over the counter medications for consumers, providers, administrators, and other participants in the healthcare industry; Providing online consumer product information in the field of pharmaceuticals and medications to meet the consumers specificationsACTIVE—
044Providing enhanced pharmacy services to patients, namely, medical analysis services in the nature of monitoring medication adherence for medical treatment of patients, comprehensive review of medications being medication counseling for treatment purposes, and healthcare services being healthcare plan development and reinforcement in the nature of monthly patient encounters to determine changes in medication regimen or health statusACTIVE—
045Providing enhanced pharmacy services to patients, namely, patient advocate and case management services in the field of communication between healthcare providers for coordinating the procurement and administration of medication for patients and prospective patients of independent community-based pharmacies; providing enhanced pharmacy services to patients, namely, care plan development and reinforcement in the nature of patient advocate and case management services in the field of coordinating the procurement and administration of medication for patients and prospective patients of independent community-based pharmacies; health care coordination, namely, case management services in the nature of coordinating medication adherence, and administration of patient medication, including immunizations for patients and prospective patients of independent community-based pharmaciesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jul 8, 2026EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jul 8, 2026EX2GSOU EXTENSION 2 GRANTED—
Jul 7, 2026EXT2SOU EXTENSION 2 FILED—
Jul 7, 2026EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jan 1, 2026EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Dec 31, 2025EX1GSOU EXTENSION 1 GRANTED—
Dec 31, 2025EXT1SOU EXTENSION 1 FILED—
Dec 31, 2025EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jul 8, 2025NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
May 13, 2025NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
May 13, 2025PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
May 7, 2025NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Apr 15, 2025CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Mar 14, 2025TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Mar 14, 2025CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Mar 14, 2025TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Mar 11, 2025GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 11, 2025GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 11, 2025CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 7, 2025TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Feb 7, 2025CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Feb 7, 2025TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Nov 7, 2024GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Nov 7, 2024GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Nov 7, 2024CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Oct 30, 2024DOCKASSIGNED TO EXAMINER—
Sep 30, 2024MDSCNOTICE OF DESIGN SEARCH CODE E-MAILED—
Sep 30, 2024NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Apr 16, 2024NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance